Skip to main content
Home
BE
  • nl
  • fr
  • en
  • Get to know Sciensano
    • About Sciensano
    • Sciensano in figures
    • Sciensano's structure
    • Contact Sciensano
    • Our commitment to quality, health, safety and environment
    • Our commitment to collecting and managing data
    • Partnerships
    • Emergency and Response
    • Working / doing an internship at Sciensano
    • Jobs
    • Values and standards
    • History of Sciensano
    • 2024 Annual report
    • Donations and bequests
  • Areas of expertise
    • List of health topics from A-Z
    • Health and disease monitoring
    • Animal Health
    • Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
    • Food consumption and food safety
    • Health and environment
    • Quality of healthcare
  • Our services
    • Analysis request
    • Data collection
    • External quality assessment
    • Control and Safety Assessment
    • Licensing
    • Health Information
    • Health Threats
    • Projects
    • Reports & Publications
  • Press Corner

Search form

/!\ Warning: site not updated

This website is a read only copy of our corporate website, as published on the 16th of September 2025, and will only be updated once a month.

This restriction is due to a number of attacks attempting to put our website down. Next update will occur on the 16th of October.

  1. Home
  2. Biblio
  3. Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022

Last updated on 2-1-2024 by Joris Van Loenhout
Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories  
Download 1.24 MB

Public Access

Published

Peer reviewed scientific article

English

DOI : https://doi.org/10.1016/j.vaccine.2023.03.069

Authors

Toon Braeye; Lucy Catteau; Ruben Brondeel; Joris Van Loenhout; Kristiaan Proesmans; Laura Cornelissen; Herman Van Oyen; Veerle Stouten; Pierre Hubin; Matthieu Billuart; Achille Djiena; Romain Mahieu; Naïma Hammami; Dieter Van Cauteren; Chloé Wyndham-Thomas

Keywords

    Article written during project(s) : 
    LINK-VACC Linking of registers for COVID-19 vaccine surveillance

    Associated health topics:

    Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories
    • DOI
    • RTF
    • Tagged
    • EndNote XML
    • RIS

    QR code

    QR code for this page URL
    Printer-friendly version

    Sciensano info

     +32 2 642 51 11
     info@sciensano.be
     contact
     +32 2 642 50 01

    Postal address

    Sciensano
    Rue Juliette Wytsmanstraat 14
    1050 Brussels, Belgium

    About us
    Sciensano jobs
    Responsibility and privacy
    Privacy notice
    Accessibility statement
    Privacy Settings

    Sciensano Logo